BridgeMD
New treatment option for Intravenous Cannulation
Official title The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access
ClinicalTrials.gov ID: NCT07279701
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if using near-infrared imaging in pediatric vein cannulation is leading to higher success rate. The main question it aims to answer is: is there higher success of first attempt in periferal vein cannulation?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 19
You may be able to join if
- Pediatric patients admitted to the inpatient section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
- Pediatric patients in the anesthesia section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
- Indicated insertion of peripheral venous access
- Consent of the patient/legal representative to the study
You likely can't join if
- Disagreement with the study
- Not indicated insertion of peripheral venous access (according to clinical condition and decision of the attending physician)
- A device for near-infrared imaging of the venous bed is not available
The study team makes the final eligibility decision.
Where it's taking place
- Brno, South Moravian, Czechia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days to 19 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brno, South Moravian, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.